About Sebia
Sebia is a company based in Evry-courcouronnes (France) founded in 1967 was acquired by CVC in October 2017. The company has 30 employees as of April 01, 2024. Sebia has completed 2 acquisitions, including Orgentec Diagnostika and ZEUS Scientific. Sebia operates in a competitive market with competitors including Neogen, Parse Biosciences, Sino Biological, Qiagen and Biofidelity, among others.
- Headquarter Evry-courcouronnes, France
- Employees 30 as on 01 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sebia Diagnostics India Private Limited
- Date of Incorporation 26 Nov, 2019
- Jurisdiction Gurugram, Haryana, India
-
Annual Revenue
$5.65 M (USD)27.76as on Mar 31, 2023
-
Net Profit
$867.77 K (USD)1433.23as on Mar 31, 2023
-
EBITDA
$764.84 K (USD)161.74as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
CVC
& 5 more
-
Employee Count
30
as on Apr 01, 2024
-
Investments & Acquisitions
Orgentec Diagnostika
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Sebia
Unlock access to complete
Funding Insights of Sebia
Investors in Sebia
Sebia has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include CVC, European Union and Astorg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Astorg is engaged in private equity investment management.
|
Locked | Locked | Locked | |
|
Mezzanine financing and equity investments are provided by CVC.
|
Locked | Locked | Locked | |
|
Private equity firm focused on energy, financial services, agriculture, and hospitality services
|
Locked | Locked | Locked |
Investor details for Sebia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sebia
Sebia has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Orgentec Diagnostika and ZEUS Scientific.
Investment portfolio details for Sebia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostics tools for Autoimmune and Infectious Diseases
|
Locked | Locked | 2009 | Locked | |
|
In vitro diagnostics for autoimmune and infectious diseases are provided.
|
Locked | Locked | 1976 | Locked |
Complete acquisition details for Sebia
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sebia
Detailed financials for Sebia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sebia Comparisons
Peer comparison for Sebia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sebia
Sebia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Parse Biosciences, Sino Biological, Qiagen and Biofidelity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
Detailed competitors of Sebia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sebia
Complete news archive for Sebia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sebia
Sebia was founded in 1967 and raised its 1st funding round 34 years after it was founded.
Sebia is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Benoit Adelus is the current CEO of Sebia.
As of Apr 01, 2024, the latest employee count at Sebia is 30.
Annual revenue of Sebia is $5.65M as on Mar 31, 2023.
Sebia was founded in 1967 and is headquartered in Evry Courcouronnes, France. The company operates in the in vitro diagnostics sector, focusing on electrophoresis technologies. Solutions for capillary and gel electrophoresis are offered, along with integrated software packages. A test menu is provided for conditions including diabetes, hematological disorders, multiple myeloma, and alcoholism. Operations emphasize diagnostic tools for clinical applications.
Sebia's top competitors include Neogen, Sino Biological and Qiagen.
Sebia has made 2 acquisitions, including Orgentec Diagnostika, and ZEUS Scientific.
Sebia has 6 investors. Key investors include CVC, European Union, Astorg, Tethys Investments, and Montagu Private Equity.